ranolazine has been researched along with Torsade de Pointes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arafune, T; Dobrev, D; Honjo, H; Kodama, I; Makita, N; Nattel, S; Niwa, R; Sakuma, I; Takanari, H; Tomii, N; Tsuji, Y; Tsuneyama, K; Yamazaki, M | 1 |
| Kawai, T; Kuninishi, Y; Muraki, Y; Nogawa, H | 1 |
| Arellano, AL; Cereza, G; Figueras, A; Montané, E; Tarapués, M | 1 |
| Lüthje, L; Maier, LS; Seegers, J; Sohns, C; Sossalla, S; Toischer, K; Vollmann, D; Wallisch, N; Zabel, M | 1 |
| Mittal, SR | 1 |
| Belardinelli, L; January, CT; Li, H; Rajamani, S; Shryock, JC; Wu, L | 1 |
| Antoons, G; Beekman, JD; Belardinelli, L; Engelen, MA; Houtman, MJ; Oros, A; Stengl, M; Vos, MA | 1 |
| Guo, D; Jia, S; Lian, J; Ma, A; Patel, C; Xue, X; Yan, GX; Yang, L; Yuan, Z | 1 |
| Belardinelli, L; Bers, DM; Grandi, E; Li, H; Luo, A; Ma, J; Shryock, JC; Wang, C; Wu, L; Zhang, P | 1 |
| Abramson, JJ; Kozhevnikov, D; Mantravadi, R; Owen, LJ; Parikh, A; Puglisi, JL; Roche, MA; Salama, G; Ye, Y | 1 |
| Antzelevitch, C; Belardinelli, L; Burashnikov, A; Cordeiro, JM; Di Diego, JM; Fish, JM; Fraser, H; Goodrow, RJ; Perez, G; Scornik, F; Wu, L; Zygmunt, AC | 1 |
| Rosovski, U; Viskin, S | 1 |
| Antzelevitch, C; Belardinelli, L; Glass, A; Goodrow, RJ; Sicouri, S; Timothy, KW; Zygmunt, AC | 1 |
| Belardinelli, L; Dhalla, AK; Robertson, C; Wang, WQ | 1 |
1 review(s) available for ranolazine and Torsade de Pointes
| Article | Year |
|---|---|
Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.
Topics: Acetanilides; Action Potentials; Angina Pectoris; Animals; Electrophysiologic Techniques, Cardiac; Humans; Ion Channels; Long QT Syndrome; Piperazines; Ranolazine; Stereoisomerism; Torsades de Pointes | 2004 |
13 other study(ies) available for ranolazine and Torsade de Pointes
| Article | Year |
|---|---|
Rotors anchored by refractory islands drive torsades de pointes in an experimental model of electrical storm.
Topics: Action Potentials; Animals; Atrioventricular Block; Defibrillators, Implantable; Disease Models, Animal; Long QT Syndrome; Rabbits; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes | 2022 |
Pharmacological characterisation of electrocardiogram J-T
Topics: Animals; DNA-Binding Proteins; Electrocardiography; Flecainide; Guinea Pigs; Long QT Syndrome; Nifedipine; Quinidine; Quinine; Ranolazine; Sotalol; Torsades de Pointes; Verapamil | 2022 |
Serious QT interval prolongation with ranolazine and amiodarone.
Topics: Acetanilides; Aged; Amiodarone; Electrocardiography; Female; Humans; Long QT Syndrome; Piperazines; Ranolazine; Sodium Channel Blockers; Torsades de Pointes | 2014 |
Effects of ranolazine on torsades de pointes tachycardias in a healthy isolated rabbit heart model.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dose-Response Relationship, Drug; Heart Conduction System; Heart Rate; In Vitro Techniques; Perfusion; Piperazines; Potassium; Rabbits; Ranolazine; Sotalol; Time Factors; Torsades de Pointes | 2014 |
Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine.
Topics: Acetanilides; Aged, 80 and over; Angina, Unstable; Benzazepines; Bradycardia; Diltiazem; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Electrocardiography; Female; Humans; Ivabradine; Long QT Syndrome; Piperazines; Ranolazine; Torsades de Pointes | 2014 |
Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Topics: 4-Aminopyridine; Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Barium Compounds; Cell Line; Chlorides; Enzyme Inhibitors; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Heart Conduction System; Humans; Kidney; Patch-Clamp Techniques; Piperazines; Piperidines; Potassium Channel Blockers; Pyridines; Rabbits; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tachycardia, Ventricular; Tetrodotoxin; Torsades de Pointes | 2009 |
Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Dogs; Lidocaine; Models, Animal; Phenethylamines; Piperazines; Potassium Channel Blockers; Ranolazine; Sodium Channels; Sulfonamides; Torsades de Pointes | 2010 |
Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Clarithromycin; Cnidarian Venoms; Heart Ventricles; Piperazines; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rabbits; Ranolazine; Sodium Channels; Sotalol; Torsades de Pointes | 2011 |
Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Bradycardia; Disease Models, Animal; Enzyme Inhibitors; Female; Heart Rate; Long QT Syndrome; Models, Cardiovascular; Myocardial Contraction; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Piperidines; Pyridines; Rabbits; Ranolazine; Sodium; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin; Torsades de Pointes | 2011 |
Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2.
Topics: Acetanilides; Action Potentials; Animals; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Enzyme Inhibitors; Female; Follow-Up Studies; Long QT Syndrome; Myocardium; Piperazines; Rabbits; Ranolazine; Ryanodine Receptor Calcium Release Channel; Torsades de Pointes; Treatment Outcome | 2012 |
The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
Topics: Acetanilides; Amiodarone; Anti-Arrhythmia Agents; Humans; Piperazines; Potassium Channel Blockers; Ranolazine; Research Design; Torsades de Pointes; Verapamil | 2005 |
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetanilides; Action Potentials; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Agonists; Disease Models, Animal; Dogs; Electrocardiography; Endocardium; Enzyme Inhibitors; Heart Ventricles; Long QT Syndrome; Myocytes, Cardiac; Patch-Clamp Techniques; Pericardium; Piperazines; Ranolazine; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Premature Complexes | 2007 |
Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
Topics: Acetanilides; Action Potentials; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Female; Heart Rate; Lidocaine; Methoxamine; Phenylephrine; Piperazines; Potassium Channel Blockers; Prazosin; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Torsades de Pointes | 2008 |